Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 16 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222470 |
| APO-IBUPROFEN | 200MG | TABLET | Resolved | 2019-02-24 | 2020-04-01 | 76717 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2023-04-14 | 2023-04-21 | 189638 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2023-11-17 | 2023-12-01 | 210733 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2024-01-12 | 2024-03-29 | 215967 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2017-07-31 | 2017-09-06 | 17609 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2017-11-28 | 2018-04-18 | 31010 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2018-07-31 | 2018-11-15 | 56986 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2018-11-30 | 2019-01-10 | 68221 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2019-03-13 | 2019-03-29 | 78512 |
| APO-IMATINIB | 100MG | TABLET | Resolved | 2021-01-29 | 2021-02-11 | 132718 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2021-04-16 | 2021-05-17 | 137578 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2021-06-25 | 2021-07-12 | 141532 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2022-02-18 | 2022-03-21 | 155314 |
| APO-IMATINIB | 100MG | TABLET | Resolved | 2022-04-08 | 2022-06-02 | 158358 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2022-04-08 | 2022-06-03 | 158361 |
| APO-IMIQUIMOD | 5% | CREAM | Resolved | 2017-03-10 | 2019-11-26 | 333 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2017-05-04 | 2017-12-14 | 8865 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2017-07-17 | 2017-12-14 | 15973 |
| APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2019-09-25 | 2020-03-02 | 94740 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |
| APO-CEFPROZIL | 500MG | TABLET | Discontinued | 2018-04-04 | 2018-10-05 | 44945 |
| APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Discontinued | 2018-12-20 | 2018-12-21 | 70250 |
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |
| APO-CIPROFLOX | 750MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60388 |
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-CITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60393 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |